Heart failure & cardiomyopathiesCohort study
Body Composition, Coronary Microvascular Dysfunction, and Future Risk of Cardiovascular Events Including Heart Failure
- Prospective cohort study
- consecutive patients
- deep learning body composition analysis
Authors' conclusion
In a predominantly female cohort of patients without flow-limiting coronary artery disease, deficient muscularity, not excess adiposity, was independently associated with CMD and future adverse outcomes, especially heart failure.
Study context
- Population
- Patients referred for evaluation of CAD with normal perfusion and preserved LVEF on cardiac stress PET
- Participants
- 400 patients
- Exposure
- Body composition and coronary flow reserve (CFR) vs coronary microvascular dysfunction (CMD) and adverse events
- Outcome
- Major adverse events, including death and hospitalization for MI or HF
- Follow-up
- Median 6.0 years
Main finding
As reported in the abstract
Major adverse events
Hazard ratio (95% CI)P value
per −1 U CFR
1.83(1.25–2.68)
P < 0.002per −10 cm²/m² SM index
1.53(1.20–1.96)
P < 0.002Each row per its own increment, as printed
Observational data: associations, not effects.
Further findings
| Outcome | Estimate | P value | |
|---|---|---|---|
| HF hospitalization — per −1 U CFR | HR 2.36 (95% CI 1.31–4.24) | P < 0.004 | |
| HF hospitalization — per −10 cm²/m² SM index | HR 1.87 (95% CI 1.30–2.69) | P < 0.004 | |
| CMD (CFR <2) · adjusted | OR 1.38 (95% CI 1.08–1.75) | P < 0.01 | |
| 0.20.5125Ratio (log scale) |
CMD (CFR <2)
- Increased subcutaneous adipose tissue (SAT) or visceral adipose tissue (VAT) not significantly associated with CMD
Interaction CFR × skeletal muscle (SM) on adverse events
- CMD with sarcopenia: highest rate of adverse events, especially young, female, obese patients
- all P < 0.005
- interaction adjusted P = 0.026
Obese (body mass index (BMI) 30.0-68.4 kg/m²) vs nonobese
- Higher SAT, VAT and SM, lower CFR with obesity
- all P < 0.001
Original publication
Body Composition, Coronary Microvascular Dysfunction, and Future Risk of Cardiovascular Events Including Heart Failure. JACC Cardiovasc Imaging. Published 27 September 2023. doi:10.1016/j.jcmg.2023.07.014
Summarised from the published abstract; every number is checked against it